Explore more publications!
Health Press Barbados
Got News to Share?

Health Press Barbados: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Press Barbados.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 23, 2025

LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial
December 23, 2025

LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial

Indeterminate GlobeNewswire
Join Jupiter Neurosciences’ Exclusive Live Investor Webinar and Q&A Session on January 6
December 23, 2025

Join Jupiter Neurosciences’ Exclusive Live Investor Webinar and Q&A Session on January 6

Indeterminate GlobeNewswire
Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th
December 23, 2025

Profound Medical Corp. Closes $36 Million Registered Direct Offering; Expects to Complete Subsequent Private Placement On or Before December 30th

Indeterminate GlobeNewswire
Trinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests 
December 23, 2025

Trinity Biotech Awarded a Major Order for 9 Million TrinScreen HIV Tests 

Indeterminate GlobeNewswire
Dyne Therapeutics Appoints Vikram Karnani to Board of Directors
December 23, 2025

Dyne Therapeutics Appoints Vikram Karnani to Board of Directors

Indeterminate GlobeNewswire
Avicanna Announces Changes to its Board of Directors
December 23, 2025

Avicanna Announces Changes to its Board of Directors

Indeterminate GlobeNewswire
Glucose Health, Inc. Completes Preferred Stock Conversion at an 85% Premium Positioning Company for Rapid Growth
December 23, 2025

Glucose Health, Inc. Completes Preferred Stock Conversion at an 85% Premium Positioning Company for Rapid Growth

Indeterminate GlobeNewswire
Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
December 23, 2025

Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID

Indeterminate GlobeNewswire
Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
December 23, 2025

Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID

Indeterminate GlobeNewswire
LAPIX Therapeutics Announces First Patient Dosed in Phase Ib Study of LPX-TI641 in Atopic Dermatitis
December 23, 2025

LAPIX Therapeutics Announces First Patient Dosed in Phase Ib Study of LPX-TI641 in Atopic Dermatitis

Indeterminate GlobeNewswire
Secura Bio Announces Participation in Gilmartin Group’s 2026 Corporate Access Event in San Francisco
December 23, 2025

Secura Bio Announces Participation in Gilmartin Group’s 2026 Corporate Access Event in San Francisco

Indeterminate GlobeNewswire
AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)
December 23, 2025

AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)

Indeterminate GlobeNewswire
Leads Biolabs And Dianthus Therapeutics Announce Initiation of Phase 1 Trial Of LBL-047 (DNTH212) In Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)
December 23, 2025

Leads Biolabs And Dianthus Therapeutics Announce Initiation of Phase 1 Trial Of LBL-047 (DNTH212) In Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE)

Indeterminate GlobeNewswire
InnoCare Announces NMPA Approval of a Phase II Clinical Trial of TYK2 Inhibitor ICP-488 for Cutaneous Lupus Erythematosus
December 23, 2025

InnoCare Announces NMPA Approval of a Phase II Clinical Trial of TYK2 Inhibitor ICP-488 for Cutaneous Lupus Erythematosus

Indeterminate GlobeNewswire
CancerVax Reviews Major Scientific and Strategic Milestones Achieved in 2025
December 23, 2025

CancerVax Reviews Major Scientific and Strategic Milestones Achieved in 2025

Indeterminate GlobeNewswire
Curium Announces First Commercial Doses of PYLCLARI® for Patients with Prostate Cancer in Poland
December 23, 2025

Curium Announces First Commercial Doses of PYLCLARI® for Patients with Prostate Cancer in Poland

Indeterminate GlobeNewswire
Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma
December 23, 2025

Press Release: Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma

Indeterminate GlobeNewswire
Communiqué de presse : Le Dupixent de Sanofi et Regeneron approuvé au Japon pour les enfants de 6 à 11 ans atteints d’asthme bronchique
December 23, 2025

Communiqué de presse : Le Dupixent de Sanofi et Regeneron approuvé au Japon pour les enfants de 6 à 11 ans atteints d’asthme bronchique

Indeterminate GlobeNewswire
Dupixent® (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma
December 23, 2025

Dupixent® (dupilumab) Approved in Japan for Children Aged 6 to 11 Years with Bronchial Asthma

Indeterminate GlobeNewswire
Vireo Growth Inc. Enters California and Florida and Strengthens Delivery Platforms with Acquisition of Eaze Inc.
December 23, 2025

Vireo Growth Inc. Enters California and Florida and Strengthens Delivery Platforms with Acquisition of Eaze Inc.

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions